Virginia Tech® home

Wenyan Ji

Research Associate (CBHDS)
  • M.A., Biostatistics, University at Buffalo, The State University of New York, 2018
  • M.E., Biochemical Engineering, Nanjing Tech University, China, 2014
  • B.S., Biotechnology, Nanjing Tech University, China, 2011
  • September 2021 – Present, Research Associate, Center for Biostatistics & Health Data Science, Department of Statistics, Virginia Tech, Roanoke, VA
  • August 2018 – September 2021, Biostatistician, Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
  • June 2018 – August 2018, Laboratory Technician, Department of Cancer Prevention & Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY
  • September 2017 – May 2018, Research Apprentice, Department of Cancer Prevention & Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY


Wenyan Ji's research interest is to design, analyze, and review pre-clinical, clinical and translational studies for a variety of disease settings and outcomes, including but not limited to Alzheimer’s disease, inflammatory bowel disease, cardiovascular disease, breast cancer, prostate cancer, gastric cancer, leukemia, Covid-19 related disease, opioid use, healthy lifestyle and tobacco use, where she is particularly interested in the development of statistical methodology and the application of appropriate statistical method especially on high dimensional data.  

See her Google Scholar profile for a complete and updated list:

  • Thaer Khoury, Saif Aljabab, Song Yao, Christine Ambrosone, Angela Omilian, Kristopher Attwood, Wenyan Ji, Shipra Gandhi (2022). Tumor-associated mononuclear cells in the tumor bed of triple-negative breast cancer associate with clinical outcomes in the post-neoadjuvant chemotherapy setting. Breast Cancer Research and Treatment, 194 (3), 531-540.

  • Amro Elshoury, Han Yu, Wenyan Ji, James E Thompson, Elizabeth A Griffiths, Amanda Przespolewski, Steven Daniel Green, Pamela J Sung, Hassan Awada, Eunice S Wang, Peter A Kouides (2022). ASXL1 Mutation Is a Novel Risk Factor for Bleeding in Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN). Blood, 138, 3637.

  • Jason Ricciuti, Aaron Varghese, Steven Gallo, Deanna Argentieri, Wenyan Ji, Alan Hutson, Jaron Mark, Emese Zsiros (2021). Using restrictive opioid protocols for postsurgical pain management does not compromise patient reported outcomes. Gynecologic Oncology, 162, S325-S326.

  • Amanda Przespolewski, Monica R Muppidi, Craig W Freyer, Wenyan Ji, Tara L Cronin, Swapna Thota, Elizabeth A Griffiths, James E Thompson, Evelena P Ontiveros, Jeffrey Baron, Amro Elshoury, Eunice S Wang (2021). Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy. Leukemia & Lymphoma, 62 (7), 1778-1781.

  • Mark Farrugia, Kayleigh Erickson, Elizabeth Wendel, Mary E Platek, Wenyan Ji, Kristopher Attwood, Sung Jun Ma, Fangyi Gu, Anurag K Singh, Andrew D Ray (2021). Change in physical performance correlates with decline in quality of life and frailty status in head and neck cancer patients undergoing radiation with and without chemotherapy. Cancers, 13 (7), 1638.

  • Emmanuel M Gabriel, Minhyung Kim, Daniel T Fisher, Catherine Mangum, Kristopher Attwood, Wenyan Ji, Debabrata Mukhopadhyay, Sanjay P Bagaria, Matthew W Robertson, Tri A Dinh, Keith L Knutson, Joseph J Skitzki, Michael B Wallace (2021). A pilot trial of intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis. Scientific reports, 11 (1), 1-13.

  • Emam, A., Hermann, G., Attwood, K., Ji, W., James, G., Kuettel, M., & Mohler, J. (2021). Oncologic outcome of radical prostatectomy versus radiotherapy as primary treatment for high and very high risk localized prostate cancer. The Prostate, 81 (4), 223–230.

  • Denslow A Trumbull, Riccardo Lemini, Tamara Díaz Vico, Matthew S Jorgensen, Kristopher Attwood, Wenyan Ji, Maureen Brady, Emmanuel Gabriel, Moshim Kukar (2021). Prognostic significance of complete pathologic response obtained with chemotherapy versus chemoradiotherapy in gastric cancer. Annals of Surgical Oncology, 28 (2), 766-773.

  • Shipra Gandhi, Manu R Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K Witkiewicz, Erik S Knudsen, Cheryl Allen, Joseph D Tario, Paul K Wallace, Carlos D Cedeno, Maria Levis, Suzanne Stack, Pauline Funchain, Joseph J Drabick, Mark J Bucsek, Igor Puzanov, Hemn Mohammadpour, Elizabeth A Repasky, Marc S Ernstoff (2021). Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity. Clinical Cancer Research, 27 (1), 87-95.

  • Ahmad Hanif, Sumera Khan, Nikhitha Mantri, Sana Hanif, Muhamed Saleh, Yamini Alla, Siddharth Chinta, Nikee Shrestha, Wenyan Ji, Kristopher Attwood, Muhammad Adrish, Kevin R Jain (2020). Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience. Annals of Hematology, 99 (10), 2323-2328.

Wenyan Ji

Research Associate (CBHDS)

Four Riverside Circle, 
Roanoke, VA 24016